Sponsor:
Johns Hopkins University
Code:
NCT07050732
Conditions
Respiratory Syncytial Virus (RSV)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Arexvy (2 doses total)
Arexvy (3 doses total)
Arexvy (1 dose total)
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-03. This information was provided to ClinicalTrials.gov by Johns Hopkins University on 2025-12-12.